Robert Bogle
General Practice · Holiday, FLNPI 1356676845
Payments from drug & device makers
Across 95 payments — averaging $19.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$344
- AstraZeneca$283
- Corcept Therapeutics$168
- Pfizer$126
- Esperion Therapeutics, Inc.$124
- Astellas Pharma US Inc$106
- plus $747 from 15 others
What the payments were for
- Food & beverage$1,80895%
- Education$905%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $344 |
| AstraZeneca(2 entities) | 14 | $283 |
| Corcept Therapeutics | 13 | $168 |
| Pfizer | 6 | $126 |
| Esperion Therapeutics, Inc. | 7 | $124 |
| Astellas Pharma US Inc | 2 | $106 |
| Exact Sciences | 5 | $104 |
| Lilly USA, LLC | 5 | $99 |
| GSK | 3 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $74 |
| Amgen | 4 | $68 |
| AbbVie | 2 | $59 |
| Bausch Health US, LLC | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Indivior Inc. | 1 | $27 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Grifols USA, LLC | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $16 |
How this compares
$1,898 in reported general payments places this provider in the 85th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 15 | $25,081 |
| EliquisApixaban | 16 | $21,164 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $10,667 |
| SynthroidLevothyroxine Sodium | 13 | $1,137 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $952 |
| Atorvastatin Calcium | 58 | $593 |
| Pantoprazole Sodium | 31 | $558 |
| Bupropion XlBupropion Hcl | 13 | $488 |
| Levothyroxine Sodium | 33 | $408 |
| Duloxetine Hcl | 14 | $405 |
| Amlodipine Besylate | 44 | $370 |
| Losartan Potassium | 39 | $362 |
| Gabapentin | 21 | $359 |
| Escitalopram Oxalate | 13 | $350 |
| Tamsulosin Hcl | 20 | $329 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $344 | $25,08115 claims |
| PfizerEliquis | $126 | $21,16416 claims |
| GSKTrelegy Ellipta | $93 | $10,66711 claims |
| AbbVieSynthroid | $59 | $1,13713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,901 general practice providers in Florida.
Other general practice in Holiday
- Jose CardonaMiami$71M
- Lawrence GalitzMiami Gardens$42.5M
- Armando AcevedoMiami$15.2M
- Jorge AmayaMiami$14.2M
- Frank AlvarezHialeah$13.6M
- Hector RodriguezMiami$12.8M
- Eddie ArmasSouth Miami$12.4M
- Idalia AcostaMiami$11.4M
- Lilia Rodriguez AblesMiami$10.7M
- Jorge Monroy AvellaOcoee$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.